SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alastair McIntosh who wrote (8704)8/26/2009 3:27:05 PM
From: TimF   of 42652
 
Why would you think that a drug company wouldn't be able to charge for the benefit of doubling or tripling survival time?

They can if they are allowed to make large profits on successful drugs.

Control drug prices and they have much less ability to do so.

Even if the body effectively controlling drug prices allowed very high prices for these drugs, that wouldn't be enough. Most drugs won't be so successful and improving survival, and until the drug is developed and tested (and perhaps not until its actually been in use for a long time), we wouldn't know which drugs will improve survival that much. Lots of drugs have to be researched, developed, and tested, in order to get a few that meet your standard. Unless its profitable to develop lots of new drugs, you won't get the lots of new drugs, so you likely won't get most of those that would have met your standards had they been developed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News